RNFT2

Across TCGA pan-cancer cohorts, RNFT2 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated RNFT2 data layer compared with 26 for mass-spec protein and 2 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher RNFT2 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated RNFT2 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

COAD, STAD, and ESCA are the cancer types where RNFT2 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.561	0.872	<.001	31	view →
STAD	OS	Median	All	0.047	0.667	<.001	27	view →
ESCA	OS	Median	All	0.114	0.704	<.001	18	view →
UCEC	OS	Median	All	1.000	0.653	.027	8	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RNFT2–COAD (OS)

Open the COAD breakdown →